In recent days, Covid-19 coronavirus has been an immense impact on social, economic fields in the world. The objective of this study determines if it is feasible to use machine learning method to evaluate how much prediction results are close to original data related to Confirmed-Negative-Released-Death cases of Covid-19. For this purpose, a verification method is proposed in this paper that uses the concept of Deep-learning Neural Network. In this framework, Long short-term memory (LSTM) and Gated Recurrent Unit (GRU) are also assimilated finally for training the dataset and the prediction results are tally with the results predicted by clinical doctors. The prediction results are validated against the original data based on some predefined metric. The experimental results showcase that the proposed approach is useful in generating suitable results based on the critical disease outbreak. It also helps doctors to recheck further verification of virus by the proposed method. The outbreak of Coronavirus has the nature of exponential growth and so it is difficult to control with limited clinical persons for handling a huge number of patients with in a reasonable time. So it is necessary to build an automated model, based on machine learning approach, for corrective measure after the decision of clinical doctors. It could be a promising supplementary confirmation method for frontline clinical doctors. The proposed method has a high prediction rate and works fast for probable accurate identification of the disease. The performance analysis shows that a high rate of accuracy is obtained by the proposed method.
This community study revealed a low prevalence and incidence of dementia with consequent low DALY-derived burden of illness compared with many industrialized nations. YLL formed major component of DALY indicating premature mortality to be an outcome of dementia burden. Copyright © 2016 John Wiley & Sons, Ltd.
Introduction: Corona Virus Infectious Disease (COVID-19) is the infectious disease. The COVID-19 disease came to earth in early 2019. It is expanding exponentially throughout the world and affected an enormous number of human beings starting from the last month. The World Health Organization (WHO) on March 11, 2020 declared COVID-19 was characterized as “Pandemic”. This paper proposed approach for confirmation of COVID-19 cases after the diagnosis of doctors. The objective of this study uses machine learning method to evaluate how much predicted results are close to original data related to Confirmed-Negative-Released-Death cases of COVID-19. Materials and methods: For this purpose, a verification method is proposed in this paper that uses the concept of Deep-learning Neural Network. In this framework, Long shrt-term memory (LSTM) and Gated Recurrent Unit (GRU) are also assimilated finally for training the dataset. The prediction results are tally with the results predicted by clinical doctors. Results: The results are obtained from the proposed method with accuracy 87 % for the “confirmed Cases”, 67.8 % for “Negative Cases”, 62% for “Deceased Case” and 40.5 % for “Released Case”. Another important parameter i.e. RMSE shows 30.15% for Confirmed Case, 49.4 % for Negative Cases, 4.16 % for Deceased Case and 13.72 % for Released Case. Conclusions: The outbreak of Coronavirus has the nature of exponential growth and so it is difficult to control with limited clinical persons for handling a huge number of patients within a reasonable time. So it is necessary to build an automated model, based on machine learning approach, for corrective measure after the decision of clinical doctors.
This is the first study in India to determine the DALY of epilepsy using GBD 2010. The results reveal a substantial burden of epilepsy in our setting. Similar such studies are needed in other parts of India in both urban and rural settings.
BACKGROUND In recent days, Covid-19 coronavirus has been an immense impact on social, economic fields in the world. The objective of this study determines if it is feasible to use machine learning method to evaluate how much prediction results are close to original data related to Confirmed-Negative-Released-Death cases of Covid-19. For this purpose, a verification method is proposed in this paper that uses the concept of Deep-learning Neural Network. In this framework, Long short-term memory (LSTM) and Gated Recurrent Unit (GRU) are also assimilated finally for training the dataset and the prediction results are tally with the results predicted by clinical doctors. The prediction results are validated against the original data based on some predefined metric. The experimental results showcase that the proposed approach is useful in generating suitable results based on the critical disease outbreak. It also helps doctors to recheck further verification of virus by the proposed method. The outbreak of Coronavirus has the nature of exponential growth and so it is difficult to control with limited clinical persons for handling a huge number of patients with in a reasonable time. So it is necessary to build an automated model, based on machine learning approach, for corrective measure after the decision of clinical doctors. It could be a promising supplementary confirmation method for frontline clinical doctors. The proposed method has a high prediction rate and works fast for probable accurate identification of the disease. The performance analysis shows that a high rate of accuracy is obtained by the proposed method. OBJECTIVE Validation of COVID-19 disease METHODS Machine Learning RESULTS 90% CONCLUSIONS The combined LSTM-GRU based RNN model provides a comparatively better results in terms of prediction of confirmed, released, negative, death cases on the data. This paper presented a novel method that could recheck occurred cases of COVID-19 automatically. The data driven RNN based model is capable of providing automated tool for confirming, estimating the current position of this pandemic, assessing the severity, and assisting government and health workers to act for good decision making policy. It could be a promising supplementary rechecking method for frontline clinical doctors. It is now essential for improving the accuracy of detection process. CLINICALTRIAL 2020-04-03 3:22:36 PM
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.